Top compounds associated with response to C18orf25


Feature Type Standardized
Nominal ANOVA
mRNA vincristine CTRPv2 pan-cancer AAC 0.068 0.03
mRNA Mitomycin-C GDSC1000 pan-cancer AAC -0.077 0.03
mRNA SN-38 CTRPv2 pan-cancer AAC 0.08 0.03
mRNA manumycin A CTRPv2 pan-cancer AAC 0.07 0.03
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.076 0.03
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.076 0.03
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.03
mRNA UNC1215 GDSC1000 pan-cancer AAC -0.074 0.03
mRNA KU-55933 GDSC1000 pan-cancer AAC 0.076 0.03
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC 0.08 0.03
Download CSV